Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
life sciences
national
6
×
national blog main
national top stories
san francisco top stories
new york top stories
san francisco blog main
texas blog main
texas top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
amgen
biogen
clinical trials
gene therapy
medicare
merck
pfizer
roche
cancer immunotherapy
deals
diagnostics
What
patients
6
×
drug
bio
medicine
roundup
cancer
fda
market
new
therapy
acquisitions
advantages
albert
allison
approved
atrophy
bar
becker
biggest
billions
bourla
brings
cancers
ceo
company
countless
crispr
daily
dollars
eaton
eisai
evrysdi
expect
fight
flags
friday
future
gamble
gene
green
Language
unset
unknown
Current search:
national
×
biotech
×
patients
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo